Which Indian pharmaceutical company acquired Sandoz's generic business in the US for $900 million?
A. Sun Pharma
B. Aurobindo Pharmaceuticals
C. Tata Chemicals
D. None of above
Answer:B
Which Indian pharmaceutical company acquired Sandoz's generic business in the US for $900 million?
A. Sun Pharma B. Aurobindo Pharmaceuticals C. Tata Chemicals D. None of above
Explanation: In the largest ever overseas pharma transaction, Aurobindo Pharmaceuticals has announced the acquisition of Sandoz's generic business in the US for $900 million. This deal is the largest such deal in pharma sector in the country. The deal gives the Hyderabad based company access to Sandoz's portfolio of oral solids and dermatology drugs and manufacturing footprint and makes it the second largest generic player in the US-based on prescriptions.